Cosmetic Dermatology — MCQs

Q: A 50-year-old man with Fitzpatrick skin type V desires treatment for melasma. He was previously treated with triple combination cream with partial response. What would be the most evidence-based next step considering safety and efficacy?

Q-switched Nd:YAG laser 1064 nm with low fluence. ***Q-switched Nd:YAG laser 1064 nm with low fluence*** - This approach, often called **laser toning**, uses a long wavelength that spares the epidermis, making it the safest laser option for **Fitzpatrick skin type V** to avoid **post-inflammatory hyperpigmentation (PIH)**. - It is a clinically sound next step for **recalcitrant melasma** that has only partially responded to first-line therapies like **triple combination cream**. *Fractional CO2 laser resurfacing* - This is an **ablative** treatment that causes significant thermal damage, which carries an unacceptably high risk of **PIH** and scarring in darker skin types. - While effective for skin remodeling, it is generally contraindicated for treating melasma in **type V skin** due to the likelihood of worsening the pigmentation. *Intense pulsed light therapy* - **IPL** uses a broad spectrum of light which is poorly targeted for melasma in dark-skinned individuals and is frequently associated with **rebound hyperpigmentation**. - The melanin in the surrounding **darker skin (Type V)** competes for the energy, leading to a high risk of **thermal burns** and uneven results. *TCA 35% chemical peel* - A 35% concentration of **Trichloroacetic acid (TCA)** is considered a **medium-depth peel**, which is generally too aggressive for patients with Fitzpatrick skin type V. - Medium-depth peels in dark skin types are likely to cause **persistent dyschromia** or permanent **hypopigmentation**, whereas superficial peels (like glycolic or salicylic acid) are safer.

Q: A patient treated with Q-switched Nd:YAG laser for nevus of Ota develops paradoxical darkening after 4 weeks. What is the most likely explanation for this phenomenon?

Increased melanogenesis due to suboptimal fluence. ***Increased melanogenesis due to suboptimal fluence*** - Paradoxical darkening in **nevus of Ota** during **Q-switched Nd:YAG** therapy often results from **suboptimal fluence**, which triggers reactive **melanogenesis** instead of destroying the target cells. - This occurs when the energy delivered is sufficient to stimulate **dermal melanocytes** but remains below the threshold required for **selective photothermolysis** and cell destruction. *Delayed clearance in deeper dermal melanocytes* - Delayed clearance typically results in a slow resolution of the lesion rather than an actual **increase in pigmentation** or darkening. - The darkening suggests an active production of **melanin** rather than a passive failure of the lymphatic system to clear debris. *Post-inflammatory hyperpigmentation due to epidermal injury* - **Post-inflammatory hyperpigmentation (PIH)** usually presents as a more generalized or superficial brownish tan following **epidermal damage**. - While common in darker skin types, the term "paradoxical darkening" in the context of dermal lesions specifically refers to the reactive stimulation of **dermal melanocytes**. *Conversion to melanoma* - There is no clinical or histopathological evidence that **Q-switched lasers** induce **malignant transformation** or conversion of a benign nevus to **melanoma**. - While **nevus of Ota** has a small baseline risk of ocular or CNS melanoma, laser-induced darkening is a transient physiological response, not a neoplastic change.

Q: A 28-year-old patient undergoes 70% glycolic acid peel for acne scars. Two hours post-procedure, he develops severe burning and erythema. What is the most appropriate immediate management?

Apply cold compresses and emollient. ***Apply cold compresses and emollient*** - Severe burning and erythema two hours post-procedure are managed with **cold compresses** to soothe inflammation and **bland emollients** to restore the skin barrier. - At this stage, the chemical agent has already been processed; management focuses on **symptomatic relief** and preventing post-inflammatory hyperpigmentation. *Apply topical steroid immediately* - Topical steroids are generally avoided immediately after a chemical peel as they may **interfere with the natural healing process** and re-epithelialization. - They are typically reserved for persistent, **prolonged erythema** that does not subside with standard post-peel care. *Start oral corticosteroids* - Systemic steroids are disproportionate for post-peel erythema and are rarely indicated unless there is a severe **systemic allergic reaction**. - Routine management of peel complications involves **local topical therapies** rather than systemic immunosuppression. *Neutralize with sodium bicarbonate solution* - Neutralization with **sodium bicarbonate** must be performed **intra-procedure** once the desired clinical endpoint (like frosting or erythema) is reached. - Two hours post-procedure is **too late** for neutralization as the acid has already been neutralized or absorbed, making this intervention ineffective.

Q: A 35-year-old woman desires correction of nasolabial folds. She has a history of herpes simplex labialis. Which dermal filler should be avoided?

Polymethylmethacrylate. ***Polymethylmethacrylate*** - **Polymethylmethacrylate (PMMA)** is a **permanent dermal filler** that carries a higher risk of **granuloma formation**, particularly in patients with recurrent viral infections like **herpes simplex labialis**. - Injecting permanent fillers into areas of high mobility like the **nasolabial folds** in patients with active or recurrent infections can lead to chronic **inflammatory complications** and reactivation of the virus. *Calcium hydroxylapatite* - This is a **semi-permanent filler** often used for deep facial folds but is not specifically contraindicated based solely on a **herpes history**, provided prophylactic antivirals are used. - It acts as a **biostimulator** and is generally safe, though it cannot be easily reversed if a complication occurs compared to hyaluronic acid. *Hyaluronic acid* - **Hyaluronic acid (HA)** is the preferred choice for this patient because it is **reversible** using the enzyme **hyaluronidase** if a flare-up or complication occurs. - While any filler can trigger a **herpes flare**, HA has a lower profile for high-grade inflammatory reactions and is considered the **gold standard** for nasolabial folds. *Poly-L-lactic acid* - This is a **biodegradable, synthetic polymer** that stimulates collagen production over time rather than providing immediate volume. - It is generally used for global facial volumization rather than targeted **nasolabial fold** correction and does not carry the specific permanent risk profile of **PMMA**.

Q: Why is botulinum toxin type A effective in reducing facial wrinkles?

It blocks acetylcholine release at neuromuscular junction. ***It blocks acetylcholine release at neuromuscular junction*** - **Botulinum toxin type A** prevents the fusion of synaptic vesicles by cleaving the **SNAP-25** protein, effectively blocking **acetylcholine** release. - This inhibition leads to **temporary muscle paralysis**, which softens **dynamic wrinkles** caused by repetitive facial muscle contractions. *It inhibits matrix metalloproteinases* - Inhibiting **matrix metalloproteinases (MMPs)** helps prevent **collagen degradation**, but this is not the mechanism of action for botulinum toxin. - MMP inhibition is typically associated with **retinoids** or photo-protection strategies rather than neurotoxins. *It directly stimulates fibroblast proliferation* - **Fibroblast proliferation** is a mechanism seen in treatments like **microneedling** or **laser therapy** to improve skin texture and volume. - **Botulinum toxin** affects the **nerve-to-muscle** signal and has no direct stimulatory effect on fibroblast cells. *It increases collagen synthesis in dermis* - Increasing **collagen synthesis** is a primary feature of **dermal fillers** or **topical retinoids**, aimed at treating static wrinkles. - While toxin use may prevent new wrinkles from deepening, its primary effect is **muscular relaxation**, not active **dermal remodeling**.

Q: Which Fitzpatrick skin type is most prone to post-inflammatory hyperpigmentation after laser therapy?

Type IV-VI. ***Type IV-VI*** - Individuals with **Fitzpatrick skin types IV-VI** have more active **melanocytes** and higher epidermal melanin, which makes them highly susceptible to **post-inflammatory hyperpigmentation (PIH)** following thermal injury. - In these types, any inflammation from **laser therapy** triggers excessive melanin production, necessitating cautious parameter selection and often pre-treatment with **tyrosinase inhibitors**. *Type I-II* - These skin types (pale white to fair) have minimal melanin and typically **burn rather than tan**, making them more prone to **erythema** but less likely to develop hyperpigmentation. - The risk of PIH is significantly lower compared to darker skin types because their **melanocytes** are less reactive to inflammatory stimuli. *Type V-VI* - While these types are at extremely high risk, this option is less comprehensive than IV-VI in identifying the full range of patients prone to laser complications. - Type V-VI patients specifically carry a high risk for **hypopigmentation** or keloid scarring if laser energy is absorbed excessively by the high baseline **chromophore** density. *Type III-IV* - Type III-IV covers fair to olive skin tones which do carry a moderate risk of PIH, but they are not the *most* prone compared to the category including Type VI. - These types typically tan well but do not represent the highest end of the **melanocyte reactivity** spectrum found in darker skin types.

Q: What is the recommended concentration of glycolic acid peel for superficial chemical peeling?

30-50%. ***30-50%*** - Glycolic acid at **30-50%** concentration is the standard range for a **superficial chemical peel**, targeting the epidermis to improve skin texture and tone. - These concentrations allow for controlled exfoliation and are commonly used to treat **acne**, **fine lines**, and **post-inflammatory hyperpigmentation**. *20-30%* - While 20-30% is mild, it is often used for skin **priming** or very light exfoliation rather than achieving the full therapeutic goals of a standard superficial peel. - This range is frequently found in lower-strength clinical formulas but is less effective for deeper **epidermal remodeling** compared to 30-50%. *10-20%* - Concentrations of **10-20%** are generally reserved for **maintenance therapy** or home-care products. - These levels are insufficient to induce the **protein coagulation** or significant cell turnover required for a formal chemical peeling session. *50-70%* - Concentrations between **50-70%** penetrate much deeper and can reach the **papillary dermis**, categorizing them as **medium-depth peels**. - Using these higher strengths carries a greater risk of **scarring** and **pigmentary changes** if not monitored strictly by a professional.

Cosmetic Dermatology Indian Medical PG Practice Questions and MCQs

Question 1: A cosmetic dermatologist plans to introduce microneedling radiofrequency for acne scars. Which parameter combination would provide optimal collagen remodeling with minimal risk of thermal injury in Fitzpatrick type IV skin?

A. Needle depth 3.5 mm, temperature 70°C, pulse duration 1000 ms
B. Needle depth 4 mm, temperature 75°C, pulse duration 500 ms
C. Needle depth 1.5-2 mm, temperature 60-65°C, pulse duration 100-200 ms (Correct Answer)
D. Needle depth 0.5 mm, temperature 55°C, pulse duration 50 ms

Explanation: ***Needle depth 1.5-2 mm, temperature 60-65°C, pulse duration 100-200 ms*** - Optimal **collagen remodeling** occurs when the tissue is heated to **60-65°C**, which triggers the denaturation of proteins and the subsequent production of new collagen and elastin. - A depth of **1.5-2 mm** specifically targets the **papillary and mid-reticular dermis**, while the shorter pulse duration minimizes **Post-Inflammatory Hyperpigmentation (PIH)** in **Fitzpatrick type IV** skin. *Needle depth 3.5 mm, temperature 70°C, pulse duration 1000 ms* - Temperatures reaching **70°C** and very high pulse durations significantly increase the risk of **thermal necrosis** and bulk heating injuries. - A depth of **3.5 mm** is often too deep for standard facial acne scarring and may damage underlying **subcutaneous structures** or cause permanent scarring. *Needle depth 4 mm, temperature 75°C, pulse duration 500 ms* - High temperatures of **75°C** cause excessive tissue coagulation, which can lead to localized **skin burns** and prolonged downtime. - Excessive needle depth combined with high energy delivery poses a severe risk for **atrophic scarring** and pigmentary changes in darker skin types. *Needle depth 0.5 mm, temperature 55°C, pulse duration 50 ms* - A depth of **0.5 mm** is generally insufficient to reach the collagen-rich dermis required for significant improvement of **depressed acne scars**. - A temperature of **55°C** is below the threshold for effective **collagen denaturation**, resulting in suboptimal clinical outcomes for scar revision.

Question 2: A 50-year-old man with Fitzpatrick skin type V desires treatment for melasma. He was previously treated with triple combination cream with partial response. What would be the most evidence-based next step considering safety and efficacy?

A. Fractional CO2 laser resurfacing
B. Q-switched Nd:YAG laser 1064 nm with low fluence (Correct Answer)
C. Intense pulsed light therapy
D. TCA 35% chemical peel

Explanation: ***Q-switched Nd:YAG laser 1064 nm with low fluence*** - This approach, often called **laser toning**, uses a long wavelength that spares the epidermis, making it the safest laser option for **Fitzpatrick skin type V** to avoid **post-inflammatory hyperpigmentation (PIH)**. - It is a clinically sound next step for **recalcitrant melasma** that has only partially responded to first-line therapies like **triple combination cream**. *Fractional CO2 laser resurfacing* - This is an **ablative** treatment that causes significant thermal damage, which carries an unacceptably high risk of **PIH** and scarring in darker skin types. - While effective for skin remodeling, it is generally contraindicated for treating melasma in **type V skin** due to the likelihood of worsening the pigmentation. *Intense pulsed light therapy* - **IPL** uses a broad spectrum of light which is poorly targeted for melasma in dark-skinned individuals and is frequently associated with **rebound hyperpigmentation**. - The melanin in the surrounding **darker skin (Type V)** competes for the energy, leading to a high risk of **thermal burns** and uneven results. *TCA 35% chemical peel* - A 35% concentration of **Trichloroacetic acid (TCA)** is considered a **medium-depth peel**, which is generally too aggressive for patients with Fitzpatrick skin type V. - Medium-depth peels in dark skin types are likely to cause **persistent dyschromia** or permanent **hypopigmentation**, whereas superficial peels (like glycolic or salicylic acid) are safer.

Question 3: A patient treated with Q-switched Nd:YAG laser for nevus of Ota develops paradoxical darkening after 4 weeks. What is the most likely explanation for this phenomenon?

A. Delayed clearance in deeper dermal melanocytes
B. Increased melanogenesis due to suboptimal fluence (Correct Answer)
C. Post-inflammatory hyperpigmentation due to epidermal injury
D. Conversion to melanoma

Explanation: ***Increased melanogenesis due to suboptimal fluence*** - Paradoxical darkening in **nevus of Ota** during **Q-switched Nd:YAG** therapy often results from **suboptimal fluence**, which triggers reactive **melanogenesis** instead of destroying the target cells. - This occurs when the energy delivered is sufficient to stimulate **dermal melanocytes** but remains below the threshold required for **selective photothermolysis** and cell destruction. *Delayed clearance in deeper dermal melanocytes* - Delayed clearance typically results in a slow resolution of the lesion rather than an actual **increase in pigmentation** or darkening. - The darkening suggests an active production of **melanin** rather than a passive failure of the lymphatic system to clear debris. *Post-inflammatory hyperpigmentation due to epidermal injury* - **Post-inflammatory hyperpigmentation (PIH)** usually presents as a more generalized or superficial brownish tan following **epidermal damage**. - While common in darker skin types, the term "paradoxical darkening" in the context of dermal lesions specifically refers to the reactive stimulation of **dermal melanocytes**. *Conversion to melanoma* - There is no clinical or histopathological evidence that **Q-switched lasers** induce **malignant transformation** or conversion of a benign nevus to **melanoma**. - While **nevus of Ota** has a small baseline risk of ocular or CNS melanoma, laser-induced darkening is a transient physiological response, not a neoplastic change.

Question 4: A 42-year-old woman develops sudden onset vision loss in one eye 2 hours after hyaluronic acid filler injection in the glabella. Fundoscopy shows retinal whitening. What is the underlying pathophysiology?

A. Compression of supraorbital nerve
B. Retrograde embolization via angular artery to ophthalmic artery (Correct Answer)
C. Direct traumatic optic nerve injury
D. Allergic reaction causing optic neuritis

Explanation: ***Retrograde embolization via angular artery to ophthalmic artery*** - Glabellar filler injection can inadvertently enter the **angular artery**, where high injection pressure forces the filler **retrograde** into the **ophthalmic artery**. - Once pressure is released, the filler travels antegrade into the **central retinal artery**, causing occlusion and classic **retinal whitening** due to ischemia. *Compression of supraorbital nerve* - This would lead to **sensory changes** or pain in the forehead region rather than sudden, painless vision loss. - Nerve compression does not explain the **fundoscopic finding** of retinal whitening or vascular compromise. *Direct traumatic optic nerve injury* - The **optic nerve** is located deep within the orbit and is not typically reachable by standard aesthetic needles used in the glabella. - Traumatic injury would likely present with an **afferent pupillary defect** without the characteristic **ischemic retinal whitening** associated with artery occlusion. *Allergic reaction causing optic neuritis* - **Optic neuritis** presents with painful eye movements and inflammatory changes, rather than the hyper-acute vision loss seen in arterial embolization. - A localized allergic reaction to **hyaluronic acid** would cause significant swelling and redness at the injection site rather than sudden **retinal ischemia**.

Question 5: A 28-year-old patient undergoes 70% glycolic acid peel for acne scars. Two hours post-procedure, he develops severe burning and erythema. What is the most appropriate immediate management?

A. Apply topical steroid immediately
B. Start oral corticosteroids
C. Neutralize with sodium bicarbonate solution
D. Apply cold compresses and emollient (Correct Answer)

Explanation: ***Apply cold compresses and emollient*** - Severe burning and erythema two hours post-procedure are managed with **cold compresses** to soothe inflammation and **bland emollients** to restore the skin barrier. - At this stage, the chemical agent has already been processed; management focuses on **symptomatic relief** and preventing post-inflammatory hyperpigmentation. *Apply topical steroid immediately* - Topical steroids are generally avoided immediately after a chemical peel as they may **interfere with the natural healing process** and re-epithelialization. - They are typically reserved for persistent, **prolonged erythema** that does not subside with standard post-peel care. *Start oral corticosteroids* - Systemic steroids are disproportionate for post-peel erythema and are rarely indicated unless there is a severe **systemic allergic reaction**. - Routine management of peel complications involves **local topical therapies** rather than systemic immunosuppression. *Neutralize with sodium bicarbonate solution* - Neutralization with **sodium bicarbonate** must be performed **intra-procedure** once the desired clinical endpoint (like frosting or erythema) is reached. - Two hours post-procedure is **too late** for neutralization as the acid has already been neutralized or absorbed, making this intervention ineffective.

Question 6: A 35-year-old woman desires correction of nasolabial folds. She has a history of herpes simplex labialis. Which dermal filler should be avoided?

A. Calcium hydroxylapatite
B. Hyaluronic acid
C. Polymethylmethacrylate (Correct Answer)
D. Poly-L-lactic acid

Explanation: ***Polymethylmethacrylate*** - **Polymethylmethacrylate (PMMA)** is a **permanent dermal filler** that carries a higher risk of **granuloma formation**, particularly in patients with recurrent viral infections like **herpes simplex labialis**. - Injecting permanent fillers into areas of high mobility like the **nasolabial folds** in patients with active or recurrent infections can lead to chronic **inflammatory complications** and reactivation of the virus. *Calcium hydroxylapatite* - This is a **semi-permanent filler** often used for deep facial folds but is not specifically contraindicated based solely on a **herpes history**, provided prophylactic antivirals are used. - It acts as a **biostimulator** and is generally safe, though it cannot be easily reversed if a complication occurs compared to hyaluronic acid. *Hyaluronic acid* - **Hyaluronic acid (HA)** is the preferred choice for this patient because it is **reversible** using the enzyme **hyaluronidase** if a flare-up or complication occurs. - While any filler can trigger a **herpes flare**, HA has a lower profile for high-grade inflammatory reactions and is considered the **gold standard** for nasolabial folds. *Poly-L-lactic acid* - This is a **biodegradable, synthetic polymer** that stimulates collagen production over time rather than providing immediate volume. - It is generally used for global facial volumization rather than targeted **nasolabial fold** correction and does not carry the specific permanent risk profile of **PMMA**.

Question 7: What is the mechanism by which tretinoin improves photoaging?

A. Upregulation of collagen synthesis and inhibition of matrix metalloproteinases (Correct Answer)
B. Inhibition of tyrosinase enzyme
C. Direct antioxidant action on free radicals
D. Enhancement of melanin degradation

Explanation: ***Upregulation of collagen synthesis and inhibition of matrix metalloproteinases*** - **Tretinoin** binds to nuclear retinoic acid receptors, leading to increased expression of **procollagen genes** (Types I and III) which restores the dermal matrix. - It effectively inhibits **matrix metalloproteinases (MMPs)** like collagenase, which are otherwise upregulated by UV radiation and responsible for **collagen degradation**. *Inhibition of tyrosinase enzyme* - While tretinoin may lead to more uniform pigment distribution, direct **tyrosinase inhibition** is the primary mechanism of agents like **hydroquinone** and **kojic acid**. - Retinoids improve hyperpigmentation primarily by increasing **epidermal turnover** and accelerating the loss of melanin. *Direct antioxidant action on free radicals* - Tretinoin does not possess significant **direct antioxidant** scavenging properties for neutralizing reactive oxygen species. - Photoprotective antioxidants usually include substances like **Vitamin C**, **Vitamin E**, or ferulic acid. *Enhancement of melanin degradation* - Melanin is not primarily degraded by tretinoin; rather, its dispersal is modified through the **thinning of the stratum corneum** and rapid cell renewal. - This process focuses on **keratinocyte shedding** rather than the enzymatic breakdown of existing melanin granules.

Question 8: Why is botulinum toxin type A effective in reducing facial wrinkles?

A. It inhibits matrix metalloproteinases
B. It blocks acetylcholine release at neuromuscular junction (Correct Answer)
C. It directly stimulates fibroblast proliferation
D. It increases collagen synthesis in dermis

Explanation: ***It blocks acetylcholine release at neuromuscular junction*** - **Botulinum toxin type A** prevents the fusion of synaptic vesicles by cleaving the **SNAP-25** protein, effectively blocking **acetylcholine** release. - This inhibition leads to **temporary muscle paralysis**, which softens **dynamic wrinkles** caused by repetitive facial muscle contractions. *It inhibits matrix metalloproteinases* - Inhibiting **matrix metalloproteinases (MMPs)** helps prevent **collagen degradation**, but this is not the mechanism of action for botulinum toxin. - MMP inhibition is typically associated with **retinoids** or photo-protection strategies rather than neurotoxins. *It directly stimulates fibroblast proliferation* - **Fibroblast proliferation** is a mechanism seen in treatments like **microneedling** or **laser therapy** to improve skin texture and volume. - **Botulinum toxin** affects the **nerve-to-muscle** signal and has no direct stimulatory effect on fibroblast cells. *It increases collagen synthesis in dermis* - Increasing **collagen synthesis** is a primary feature of **dermal fillers** or **topical retinoids**, aimed at treating static wrinkles. - While toxin use may prevent new wrinkles from deepening, its primary effect is **muscular relaxation**, not active **dermal remodeling**.

Question 9: Which Fitzpatrick skin type is most prone to post-inflammatory hyperpigmentation after laser therapy?

A. Type I-II
B. Type V-VI
C. Type III-IV
D. Type IV-VI (Correct Answer)

Explanation: ***Type IV-VI*** - Individuals with **Fitzpatrick skin types IV-VI** have more active **melanocytes** and higher epidermal melanin, which makes them highly susceptible to **post-inflammatory hyperpigmentation (PIH)** following thermal injury. - In these types, any inflammation from **laser therapy** triggers excessive melanin production, necessitating cautious parameter selection and often pre-treatment with **tyrosinase inhibitors**. *Type I-II* - These skin types (pale white to fair) have minimal melanin and typically **burn rather than tan**, making them more prone to **erythema** but less likely to develop hyperpigmentation. - The risk of PIH is significantly lower compared to darker skin types because their **melanocytes** are less reactive to inflammatory stimuli. *Type V-VI* - While these types are at extremely high risk, this option is less comprehensive than IV-VI in identifying the full range of patients prone to laser complications. - Type V-VI patients specifically carry a high risk for **hypopigmentation** or keloid scarring if laser energy is absorbed excessively by the high baseline **chromophore** density. *Type III-IV* - Type III-IV covers fair to olive skin tones which do carry a moderate risk of PIH, but they are not the *most* prone compared to the category including Type VI. - These types typically tan well but do not represent the highest end of the **melanocyte reactivity** spectrum found in darker skin types.

Question 10: What is the recommended concentration of glycolic acid peel for superficial chemical peeling?

A. 20-30%
B. 10-20%
C. 50-70%
D. 30-50% (Correct Answer)

Explanation: ***30-50%*** - Glycolic acid at **30-50%** concentration is the standard range for a **superficial chemical peel**, targeting the epidermis to improve skin texture and tone. - These concentrations allow for controlled exfoliation and are commonly used to treat **acne**, **fine lines**, and **post-inflammatory hyperpigmentation**. *20-30%* - While 20-30% is mild, it is often used for skin **priming** or very light exfoliation rather than achieving the full therapeutic goals of a standard superficial peel. - This range is frequently found in lower-strength clinical formulas but is less effective for deeper **epidermal remodeling** compared to 30-50%. *10-20%* - Concentrations of **10-20%** are generally reserved for **maintenance therapy** or home-care products. - These levels are insufficient to induce the **protein coagulation** or significant cell turnover required for a formal chemical peeling session. *50-70%* - Concentrations between **50-70%** penetrate much deeper and can reach the **papillary dermis**, categorizing them as **medium-depth peels**. - Using these higher strengths carries a greater risk of **scarring** and **pigmentary changes** if not monitored strictly by a professional.

Question 11: Berloque dermatitis is due to contact with which of the following?

A. Plants
B. Food
C. Cosmetics (Correct Answer)
D. Metal

Explanation: **Explanation:** **Berloque dermatitis** (also known as "pendant dermatitis") is a specific form of **Phytophotodermatitis**. It occurs due to the application of **cosmetics**, specifically perfumes or colognes containing **Bergamot oil** (derived from the rind of *Citrus bergamia*). 1. **Mechanism:** Bergamot oil contains **Bergapten (5-methoxypsoralen)**, a potent photosensitizer. When the perfume is applied to the skin (often the neck or wrists) and subsequently exposed to **Ultraviolet A (UVA)** light, a phototoxic reaction occurs. This results in acute erythema followed by characteristic "pendant-like" or "streak-like" hyperpigmentation. 2. **Why other options are incorrect:** * **Plants:** While many plants (like carrots, celery, or limes) cause phytophotodermatitis, the specific term "Berloque" is reserved for reactions caused by perfumes/cosmetics. * **Food:** Ingestion of specific foods does not cause this localized streak-like dermatitis. * **Metal:** Metal contact typically causes Allergic Contact Dermatitis (Type IV hypersensitivity), such as Nickel dermatitis, which does not require sunlight to manifest. **Clinical Pearls for NEET-PG:** * **Etiology:** 5-Methoxypsoralen (Bergapten) + UVA light. * **Clinical Feature:** Hyperpigmentation in the shape of perfume droplets or streaks (Berloque is French for "trinket" or "pendant"). * **Type of Reaction:** It is a **Phototoxic** reaction (non-immunologic), not photoallergic. * **Other related conditions:** *Dermatitis pratensis* (meadow grass dermatitis) is the plant-induced counterpart.

Question 12: A 30-year-old woman presents with a cosmetic complaint shown in the image. What is the clinical diagnosis?

A. Xanthelasma (Correct Answer)
B. Necrobiosis lipoidica
C. Tuberous xanthoma
D. Orbital lipogranuloma

Explanation: ***Xanthelasma*** - The image shows **yellowish, plaque-like lesions** on the **eyelids**, which are characteristic of xanthelasma. These lesions are **deposits of cholesterol** within macrophages in the skin. - Xanthelasma is often associated with **dyslipidemia**, though it can also occur in individuals with normal lipid levels. *Necrobiosis lipoidica* - This condition typically presents as **sharply demarcated, yellowish-brown plaques** with an atrophic, waxy center, often on the **shins**. - It is frequently associated with **diabetes mellitus** and does not typically involve the eyelids in this manner. *Tuberous xanthoma* - Tuberous xanthomas are **firm, painless nodules** that typically appear over **extensor surfaces** such as elbows, knees, and Achilles tendons. - They are also fat deposits but differ in morphology and location from the eyelid lesions seen here. *Orbital lipogranuloma* - An orbital lipogranuloma is an **inflammatory mass within the orbit** that can cause proptosis or swelling around the eye. - It is an internal orbital mass, not a superficial skin lesion on the eyelids as depicted.

Question 13: Which of the following statements about spider telangiectasia is false?

A. More common in males (Correct Answer)
B. Light therapy for treatment
C. May be associated with liver disease
D. Can be caused by trauma

Explanation: ***More common in males*** - This statement is **FALSE** because spider telangiectasias (spider nevi/spider angiomas) are more commonly observed in **females**, often due to hormonal influences like **estrogen**. - They are frequently associated with conditions such as **pregnancy**, **oral contraceptive use**, or **chronic liver disease**, highlighting a female predominance. - The estrogen-dependent nature explains their higher prevalence in women of reproductive age. *Can be caused by trauma* - This statement is **TRUE** in a broader sense, though classical spider telangiectasias are primarily hormonally-mediated rather than traumatic. - While **simple telangiectasias** can develop after localized trauma or repeated pressure, spider telangiectasias have a characteristic morphology (central arteriole with radiating vessels) and are typically associated with **estrogen excess** or **liver disease**. - For exam purposes, this is considered a true statement as telangiectatic vessels can be influenced by local factors. *Light therapy for treatment* - This statement is **TRUE**. **Laser therapy**, specifically **pulsed dye laser (PDL)** or **intense pulsed light (IPL)**, is the most effective treatment for spider telangiectasias. - The laser selectively targets **hemoglobin** in the dilated vessels, causing photocoagulation and vessel obliteration, leading to excellent cosmetic results. *May be associated with liver disease* - This statement is **TRUE**. Spider telangiectasias are a well-recognized cutaneous manifestation of **chronic liver disease**, especially **cirrhosis**. - Impaired hepatic function leads to decreased **estrogen metabolism** (hyperestrogenemia), contributing to the development of these vascular lesions. - They are one of the stigmata of chronic liver disease, along with palmar erythema and gynecomastia.

Practice by Chapter

Photoaging

Practice Questions

Cosmeceuticals

Practice Questions

Chemical Peels

Practice Questions

Botulinum Toxin

Practice Questions

Soft Tissue Augmentation

Practice Questions

Laser Resurfacing

Practice Questions

Light-Based Therapies

Practice Questions

Hair Removal Techniques

Practice Questions

Sclerotherapy for Varicose and Spider Veins

Practice Questions

Treatment of Pigmentary Disorders

Practice Questions

Body Contouring Procedures

Practice Questions

Cosmetic Complications and Management

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free